Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.

Pelon F, Bourachot B, Kieffer Y, Magagna I, Mermet-Meillon F, Bonnet I, Costa A, Givel AM, Attieh Y, Barbazan J, Bonneau C, Fuhrmann L, Descroix S, Vignjevic D, Silberzan P, Parrini MC, Vincent-Salomon A, Mechta-Grigoriou F.

Nat Commun. 2020 Jan 21;11(1):404. doi: 10.1038/s41467-019-14134-w.

2.

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer.

Picardo F, Romanelli A, Muinelo-Romay L, Mazza T, Fusilli C, Parrella P, Barbazán J, Lopez-López R, Barbano R, De Robertis M, Taffon C, Bordoni V, Agrati C, Costantini M, Ricci F, Graziano P, Maiello E, Muscarella LA, Fazio VM, Poeta ML.

Cancers (Basel). 2019 Oct 19;11(10). pii: E1598. doi: 10.3390/cancers11101598.

3.

Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors.

Ear J, Dunkel Y, Mittal Y, Lim BBC, Liu L, Holda MK, Nitsche U, Barbazán J, Goel A, Janssen KP, Aznar N, Ghosh P.

Sci Rep. 2019 Aug 20;9(1):12124. doi: 10.1038/s41598-019-48420-w.

4.

Cancer cells in the tumor core exhibit spatially coordinated migration patterns.

Staneva R, El Marjou F, Barbazan J, Krndija D, Richon S, Clark AG, Vignjevic DM.

J Cell Sci. 2019 Mar 15;132(6). pii: jcs220277. doi: 10.1242/jcs.220277.

5.

Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.

Cacheux W, Lièvre A, Richon S, Vacher S, El Alam E, Briaux A, El Botty R, Mariani P, Buecher B, Schnitzler A, Barbazan J, Roman-Roman S, Bièche I, Dangles-Marie V.

Int J Cancer. 2019 Oct 1;145(7):1852-1859. doi: 10.1002/ijc.32178. Epub 2019 Feb 18.

PMID:
30714617
6.

Cancer associated fibroblasts: is the force the path to the dark side?

Barbazán J, Matic Vignjevic D.

Curr Opin Cell Biol. 2019 Feb;56:71-79. doi: 10.1016/j.ceb.2018.09.002. Epub 2018 Oct 9. Review.

PMID:
30308331
7.

Cell Migration in Tissues: Explant Culture and Live Imaging.

Staneva R, Barbazan J, Simon A, Vignjevic DM, Krndija D.

Methods Mol Biol. 2018;1749:163-173. doi: 10.1007/978-1-4939-7701-7_13.

PMID:
29525997
8.

PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.

Alonso-Alconada L, Barbazan J, Candamio S, Falco JL, Anton C, Martin-Saborido C, Fuster G, Sampedro M, Grande C, Lado R, Sampietro-Colom L, Crego E, Figueiras S, Leon-Mateos L, Lopez-Lopez R, Abal M.

Clin Transl Oncol. 2018 May;20(5):630-638. doi: 10.1007/s12094-017-1760-9. Epub 2017 Oct 20. Review.

PMID:
29058262
9.

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.

Insua YV, Cámara J, Vázquez EB, Fernández A, Rivera FV, Silva MJVV, Barbazán J, Muinelo-Romay L, Folgar SC, Abalo A, López-López R, Abal M, Alonso-Alconada L.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1265. doi: 10.3390/ijms18061265.

10.

Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.

Barbazán J, Alonso-Alconada L, Elkhatib N, Geraldo S, Gurchenkov V, Glentis A, van Niel G, Palmulli R, Fernández B, Viaño P, Garcia-Caballero T, López-López R, Abal M, Vignjevic DM.

Cancer Res. 2017 Jul 1;77(13):3431-3441. doi: 10.1158/0008-5472.CAN-16-1917. Epub 2017 May 23.

11.

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.

Mariscal J, Alonso-Nocelo M, Muinelo-Romay L, Barbazan J, Vieito M, Abalo A, Gomez-Tato A, Maria de Los Angeles CC, Garcia-Caballero T, Rodriguez C, Brozos E, Baron F, Lopez-Lopez R, Abal M.

Sci Rep. 2016 Nov 30;6:37820. doi: 10.1038/srep37820.

12.

Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer.

Barbazan J, Dunkel Y, Li H, Nitsche U, Janssen KP, Messer K, Ghosh P.

Sci Rep. 2016 Feb 26;6:22112. doi: 10.1038/srep22112.

13.

Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation.

de la Cruz-Herrera CF, Baz-Martínez M, Lang V, El Motiam A, Barbazán J, Couceiro R, Abal M, Vidal A, Esteban M, Muñoz-Fontela C, Nieto A, Rodríguez MS, Collado M, Rivas C.

Oncogene. 2016 Jun 2;35(22):2873-80. doi: 10.1038/onc.2015.356. Epub 2015 Sep 28.

PMID:
26411363
14.

Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Aznar N, Midde KK, Dunkel Y, Lopez-Sanchez I, Pavlova Y, Marivin A, Barbazán J, Murray F, Nitsche U, Janssen KP, Willert K, Goel A, Abal M, Garcia-Marcos M, Ghosh P.

Elife. 2015 Jun 30;4:e07091. doi: 10.7554/eLife.07091.

15.

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.

Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M.

Carcinogenesis. 2014 Dec;35(12):2679-86. doi: 10.1093/carcin/bgu198. Epub 2014 Sep 18.

PMID:
25233929
16.

A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.

Barbazán J, Muinelo-Romay L, Vieito M, Candamio S, Díaz-López A, Cano A, Gómez-Tato A, Casares de Cal Mde L, Abal M, López-López R.

Int J Cancer. 2014 Dec 1;135(11):2633-43. doi: 10.1002/ijc.28910. Epub 2014 Apr 29.

17.

Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.

Barbazán J, Alonso-Alconada L, Muinelo-Romay L, Vieito M, Abalo A, Alonso-Nocelo M, Candamio S, Gallardo E, Fernández B, Abdulkader I, de Los Ángeles Casares M, Gómez-Tato A, López-López R, Abal M.

PLoS One. 2012;7(7):e40476. doi: 10.1371/journal.pone.0040476. Epub 2012 Jul 10.

18.

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.

Barbazán J, Vieito M, Abalo A, Alonso-Alconada L, Muinelo-Romay L, Alonso-Nocelo M, León L, Candamio S, Gallardo E, Anido U, Doll A, de los Ángeles Casares M, Gómez-Tato A, Abal M, López-López R.

J Cell Mol Med. 2012 Oct;16(10):2342-9. doi: 10.1111/j.1582-4934.2012.01544.x.

19.

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies.

Muinelo-Romay L, Alonso-Alconada L, Alonso-Nocelo M, Barbazan J, Abal M.

Curr Mol Med. 2012 Jul 1;12(6):746-62. Review.

PMID:
22292441
20.

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

Colas E, Muinelo-Romay L, Alonso-Alconada L, Llaurado M, Monge M, Barbazan J, Gonzalez M, Schoumacher M, Pedrola N, Ertekin T, Devis L, Ruiz A, Castellvi J, Doll A, Gil-Moreno A, Vazquez-Levin M, Lapyckyj L, Lopez-Lopez R, Robine S, Friederich E, Castro M, Reventos J, Vignjevic D, Abal M.

Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.

PMID:
22266854
21.

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M, Curiel T, Cueva J, Anido U, Forteza J, Gil-Moreno A, Reventos J, Lopez-Lopez R, Abal M.

Mol Cancer Ther. 2011 Aug;10(8):1357-66. doi: 10.1158/1535-7163.MCT-10-1019. Epub 2011 May 25.

Supplemental Content

Loading ...
Support Center